Jagat Pal Yadav

Dr. Jagat Pal Yadav

Sam Higginbottom Institute of Agriculture, Allahabad, India
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
AKAdarsh kumar
Adarsh kumar
ASAnkit kumar singh
Ankit kumar singh
HSHarshwardhan Singh
Harshwardhan Singh
VVVeena Vijayan
Veena Vijayan
DKDeepak Kumar
Deepak Kumar
PKPradeep Kumar
Pradeep Kumar
Cancer is one of the major healthcare challenges across the globe. Several anticancer drugs are available on the market but they either lack specificity or have poor safety, severe side effects, and suffer from resistance. So, there is a dire need to develop safer and target-specific anticancer drugs. More than 85% of all physiologically active pharmaceuticals are heterocycles or contain at least one heteroatom. Nitrogen heterocycles constituting the most common heterocyclic framework. In this study, we have compiled the FDA approved heterocyclic drugs with nitrogen atoms and their pharmacological properties. Moreover, we have reported nitrogen containing heterocycles, including pyrimidine, quinolone, carbazole, pyridine, imidazole, benzimidazole, triazole, β-lactam, indole, pyrazole, quinazoline, quinoxaline, isatin, pyrrolo-benzodiazepines, and pyrido[2,3-d]pyrimidines, which are used in the treatment of different types of cancer, concurrently covering the biochemical mechanisms of action and cellular targets.

28 August 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
ASAnkit kumar singh
Ankit kumar singh
AKAdarsh kumar
Adarsh kumar
HSHarshwardhan Singh
Harshwardhan Singh
PSPankaj Sonawane
Pankaj Sonawane
HPHarshali Paliwal
Harshali Paliwal
PKPradeep Kumar
Pradeep Kumar
Cancer is a complex disease, and its treatment is a big challenge, with variable efficacy of conventional anticancer drugs. A two-drug cocktail hybrid approach is a potential strategy in recent drug discovery that involves the combination of two drug pharmacophores into a single molecule. The hybrid molecule acts through distinct modes of action on several targets at a given time with more efficacy and less susceptibility to resistance. Thus, there is a huge scope for using hybrid compounds to tackle the present difficulties in cancer medicine. Recent work has applied this technique to uncover some interesting molecules with substantial anticancer properties. In this study, we report data on numerous promising hybrid anti-proliferative/anti-tumor agents developed over the previous 10 years (2011–2021). It includes quinazoline, indole, carbazole, pyrimidine, quinoline, quinone, imidazole, selenium, platinum, hydroxamic acid, ferrocene, curcumin, triazole, benzimidazole, isatin, pyrrolo benzodiazepine (PBD), chalcone, coumarin, nitrogen mustard, pyrazole, and pyridine-based anticancer hybrids produced via molecular hybridization techniques. Overall, this review offers a clear indication of the potential benefits of merging pharmacophoric subunits from multiple different known chemical prototypes to produce more potent and precise hybrid compounds. This provides valuable knowledge for researchers working on complex diseases such as cancer.

4 July 2024 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
Jagat Pal YadavJagat Pal Yadav
Jagat Pal Yadav
AVAmita Verma
Amita Verma
PPPrateek Pathak
Prateek Pathak
ADAshish R. Dwivedi
Ashish R. Dwivedi
ASAnkit Kumar Singh
Ankit Kumar Singh
DPDinesh Kumar Patel
Dinesh Kumar Patel
The NF-κB pathway plays a pivotal role in impeding the diabetic wound healing process, contributing to prolonged inflammation, diminished angiogenesis, and reduced proliferation. In contrast to modern synthetic therapies, naturally occurring phytoconstituents are well-studied inhibitors of the NF-κB pathway that are now attracting increased attention in the context of diabetic wound healing because of lower toxicity, better safety and efficacy, and cost-effectiveness. This study explores recent research on phytoconstituent-based therapies and delve into their action mechanisms targeting the NF-κB pathway and potential for assisting effective healing of diabetic wounds. For this purpose, we have carried out surveys of recent literature and analyzed studies from prominent databases such as Science Direct, Scopus, PubMed, Google Scholar, EMBASE, and Web of Science. The classification of phytoconstituents into various categorie such as: alkaloids, triterpenoids, phenolics, polyphenols, flavonoids, monoterpene glycosides, naphthoquinones and tocopherols. Noteworthy phytoconstituents, including Neferine, Plumbagin, Boswellic acid, Genistein, Luteolin, Kirenol, Rutin, Vicenin-2, Gamma-tocopherol, Icariin, Resveratrol, Mangiferin, Betulinic acid, Berberine, Syringic acid, Gallocatechin, Curcumin, Loureirin-A, Loureirin-B, Lupeol, Paeoniflorin, and Puerarin emerge from these studies as promising agents for diabetic wound healing through the inhibition of the NF-κB pathway. Extensive research on various phytoconstituents has revealed how they modulate signalling pathways, including NF-κB, studies that demonstrate the potential for development of therapeutic phytoconstituents to assist healing of chronic diabetic wounds.

1 June 2024 in Intelligent Pharmacy
Verified
Journal Article
Open access
SYSeema Yadav
Seema Yadav
ASAbhishek Singh
Abhishek Singh
RSRishika Singhal
Rishika Singhal
Jagat Pal YadavJagat Pal Yadav
Jagat Pal Yadav

11 January 2024 in Inflammopharmacology
Verified
Journal Article
Closed access
PDF file
Jagat Pal YadavJagat Pal Yadav
Jagat Pal Yadav
ASAnkit Kumar Singh
Ankit Kumar Singh
MGMaria Grishina
Maria Grishina
PPPrateek Pathak
Prateek Pathak
AVAmita Verma
Amita Verma
DPDinesh Kumar Patel
Dinesh Kumar Patel

5 November 2024 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
SYSeema Yadav
Seema Yadav
ASAbhishek Singh
Abhishek Singh
NPNarahari Narayan Palei
Narahari Narayan Palei
PPPrateek Pathak
Prateek Pathak
AVAmita Verma
Amita Verma
Jagat Pal YadavJagat Pal Yadav
Jagat Pal Yadav